Submit Your Feeds

Business News • PR NewsWire • New Phase III Data in Asthma Patients Show Tiotropium Improves Lung Function, Regardless of Allergic Status

New Phase III Data in Asthma Patients Show Tiotropium Improves Lung Function, Regardless of Allergic Status
New Phase III Data in Asthma Patients Show Tiotropium Improves Lung Function, Regardless of Allergic Status

HOUSTON, Feb. 21, 2015 /PRNewswire/ -- Boehringer Ingelheim today presented data on investigational tiotropium delivered via Respimat® inhaler from five Phase III trials from the UniTinA-asthma® program at the 2015 American Academy of Allergy, Asthma & Immunology...

View More : http://www.prnewswire.com/news-releases/new-phase-iii-data-in-asthma-patients-show-tiotropium-improves-lung-function-reg...
Releted News by prnewswire
New Phase III Data in Asthma Patients Show Tiotropium Improves Lung Function, Regardless of Allergic Status
Global Network for Rights and Development (GNRD) International Conference in Geneva Introduces a New Convention on Collective Cooperation in Counter-Terrorism
Aggressive Growth in Cloud Security Software Market Forecast Globally to 2019
2015 Film Independent Spirit Awards Winners Announced
Home Sitemap Contact Us
© businessNewsNewsNews.com